- 专利标题: Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method
-
申请号: US16845184申请日: 2020-04-10
-
公开(公告)号: US11266608B2公开(公告)日: 2022-03-08
- 发明人: Jennifer J. Kang-Mieler , Eric Brey , Victor Perez-Luna , Bin Jiang , Christian Osswald
- 申请人: Jennifer J. Kang-Mieler
- 申请人地址: US IL Winnetka
- 专利权人: Jennifer J. Kang-Mieler
- 当前专利权人: Jennifer J. Kang-Mieler
- 当前专利权人地址: US IL Winnetka
- 代理机构: Pauley Erickson & Swanson
- 主分类号: A61K9/51
- IPC分类号: A61K9/51 ; A61K9/06 ; A61K9/00 ; A61K9/50
摘要:
A hydrogel delivery composition and method, including degradable microcapsules suspended in a degradable thermo-responsive hydrogel. The hydrogel is thermo-responsive at a physiological temperature and changes after application to a more solid state due to body temperatures. The composition includes one or more treatment agents to be released over time as the composition degrades. The composition can be varied to modify the structure and/or release of the treatment agent. The degradable microcapsules include one or more of magnesium hydroxide (Mg(OH)2), bovine serum albumin (BSA), polyethylene glycol (PEG), and sucrose to improve release duration.
信息查询